Abstract
The HIV-1 Tat gene is required for virus replication and disease. Tat was reported to be released from infected cells. Recombinant soluble Tat may be taken up by many cell types and transported to the nucleus as an active transcription factor leading to upregulation of viral replication in bystander cells. However, numerous attempts to use Tat protein or Tat expressing constructs for protective immunization in non human primate model produced controversial results, leading us to ask whether the effects of Tat might be indirect and result from increased expression of secondary mediators like cytokines or growth factors. Immunization with Tat protein produces antibodies to a limited number of linear epitopes in animals and human beings, mainly located in the N-terminus of the molecule. We generated a unique prototypic monoclonal antibody TR1 that recognizes an epitope in the N-terminus of HIV1 Tat and inhibits Tat uptake by reporter cells. This antibody strongly neutralizes recombinant Tat protein in a cellular assay for the induction of a latent Tat deficient HIV-1 provirus. Expression of Tat protein in different cell types leads to the accumulation of a transactivation in culture medium. However, 1) this activity cannot be inhibited by Tat-neutralizing antibody TR1;
Highlights
A HIV-1 Stimulating Host Factor Induced by HIV-1 Tat Protein
national Meeting of The Institute of Human Virology Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. [link 'here' using 'a href' to: http://www.biomedcentral.com/content/pdf/1742-4690-2-S1
Recombinant soluble Tat may be taken up by many cell types and transported to the nucleus as an active transcription factor leading to upregulation of viral replication in bystander cells
Summary
A HIV-1 Stimulating Host Factor Induced by HIV-1 Tat Protein Ilia Tikhonov*‡, Shannon Berg, Tracy Ruckwardt and Dave Pauza Address: Institute of Human Virology, Baltimore, Maryland * Corresponding author ‡Presenting author from 2005 International Meeting of The Institute of Human Virology Baltimore, USA, 29 August – 2 September 2005
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have